[1]
Shukla, N.; Siva, N.; Malik, B.; Suravajhala, P. Current challenges and implications of proteogenomic approaches in prostate cancer. Curr. Top. Med. Chem., 2020, 20(22), 1968-1980.
[2]
Bhagat, M.; Kumar, A.; Suravajhala, R. Cedrus deodara (Bark) essential oil induces apoptosis in human colon cancer cells by inhibiting nuclear factor kappa B. Curr. Top. Med. Chem., 2020, 20(22), 1981-1992.
Current Topics in Medicinal Chemistry
Title:Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy – Part-4
Volume: 20 Issue: 22
Author(s): Suman S. Thakur
Affiliation:
Export Options
About this article
Cite this article as:
Thakur S. Suman , Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy – Part-4, Current Topics in Medicinal Chemistry 2020; 20 (22) . https://dx.doi.org/10.2174/156802662022200917110723
DOI https://dx.doi.org/10.2174/156802662022200917110723 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
23
4
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges
Current Drug Targets In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
Current Pharmaceutical Design Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry n-3 Polyunsaturated Fatty Acids as Signal Transduction Modulators and Therapeutical Agents in Cancer
Current Signal Transduction Therapy The Activating Receptors of Natural Killer Cells and Their Inter-Switching Potentials
Current Drug Targets Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors
Current Pharmacogenomics Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Thioredoxin System Modulation by Plant and Fungal Secondary Metabolites
Current Medicinal Chemistry Collagenolytic Enzymes and their Applications in Biomedicine
Current Medicinal Chemistry The Interest of Folic Acid in Targeted Photodynamic Therapy
Current Medicinal Chemistry Nanoparticles Based on Plasma Proteins for Drug Delivery Applications
Current Pharmaceutical Design Ribozymes in the Age of Molecular Therapeutics
Current Molecular Medicine The Neuroendocrine Component in Bladder Tumors
Current Medicinal Chemistry Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Current Pharmaceutical Design Drug-Mediated Targeted Disruption of Multiple Protein Activities Through Functional Inhibition of the Hsp90 Chaperone Complex
Current Medicinal Chemistry Review of Structures Containing Fullerene-C60 for Delivery of Antibacterial Agents. Multitasking model for Computational Assessment of Safety Profiles
Current Bioinformatics Rediscovering Tocophersolan: A Renaissance for Nano-Based Drug Delivery and Nanotheranostic Applications
Current Drug Targets Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways
Current Neuropharmacology Identification of Inflammatory, Metabolic, and Cell Survival Pathways Contributing to Cerebral Small Vessel Disease by Postmortem Gene Expression Microarray
Current Neurovascular Research